Table 1.
Demographics and Clinical Characteristics of Patients with Type 2 Diabetes initiated on V-Go (n = 60).
| Variable | n = 60 |
|---|---|
| Female, n (%) | 35 (58.3) |
| Age | |
| Mean (SD), years | 52.0 (10.7) |
| Range (Min-Max), years | 32-81 |
| ≤45 years, n (%) | 21 (35.0) |
| 46-55 years, n (%) | 16 (26.7) |
| 56-65 years, n (%) | 20 (33.3) |
| >65 years, n (%) | 3 (5.0) |
| Race | |
| African American, n (%) | 22 (36.7) |
| Caucasian, n (%) | 38 (63.3) |
| Years with diabetes diagnosis | |
| Mean (SD), years | 13.0 (6.5) |
| >10 years, n (%) | 36 (60.0) |
| Between 5-10 years, n (%) | 12 (20.0) |
| <5 years, n (%) | 4 (6.7) |
| Unknown duration of diabetes, n (%) | 8 (13.3) |
| Baseline HbA1ca | |
| Mean (SD), % | 9.1 (1.7) |
| <7% (53 mmol/mol), n (%) | 5 (8.3) |
| 7-7.9% (53-63 mmol/mol), n (%) | 11 (18.3) |
| 8-8.9% (64-74 mmol/mol), n (%) | 15 (25.0) |
| 9-9.9% (75-85 mmol/mol), n (%) | 14 (23.3) |
| 10-10.9% (86-96 mmol/mol), n (%) | 7 (11.7) |
| ≥11%(≥97 mmol/mol), n (%) | 8 (13.3) |
| Weight, mean (SD), pounds | 223.0 (44.0) |
| BMI, mean (SD), kg/m2 | 34.4 (6.1) |
| Normal, 18.5–24.9, n (%) | 3 (5.0) |
| Overweight, 25.0–29.9, n (%) | 13 (21.7) |
| Obese, ≥30.0, n (%) | 44 (73.3) |
| Initial V-Go prescription | |
| V-Go 20, n (%) | 18 (30) |
| V-Go 30, n (%) | 17 (28.3) |
| V-Go 40, n (%) | 25 (41.7) |
a
Prior to V-Go initiation.